Search
Search Results
##search.searchResults.foundPlural##
-
OPTIMIZING TREATMENT, MINIMIZING RISK: THERAPEUTIC DRUG MONITORING IN HEMATOLOGICAL MALIGNANCIES
1915PDF: 2138Suppl. Files: 296HTML: 124 -
COST OF HEMATOPOIETIC STEM CELL TRANSPLANTATION IN INDIA
2934PDF: 1051HTML: 4754 -
Successful Outcomes of Severe COVID-19 in Patient with Chronic Lymphocytic Leukemia: Diagnostic Challenges in Immunocompromised Hosts COVID-19 in cancer patients
1348PDF: 861HTML: 267 -
OUTBREAK OF BURKHOLDERIA CEPACIA INFECTION: A SYSTEMATIC STUDY IN A HEMATOLOGY-ONCOLOGY UNIT OF A TERTIARY CARE HOSPITAL FROM EASTERN INDIA.
2458PDF: 1037HTML: 532Outbreak of Burkholderia cepacia infection: a systematic study in a hematolo-oncology unit of a tertiary care hospital from Eastern India: 269UntitOutbreak of Burkholderia cepacia infection: a systematic study in a hematolo-oncology unit of a tertiary care hospital from Eastern Indialed: 415Outbreak of Burkholderia cepacia infection: a systematic study in a hematolo-oncology unit of a tertiary care hospital from Eastern India: 318Outbreak of Burkholderia cepacia infection: a systematic study in a hematolo-oncology unit of a tertiary care hospital from Eastern India: 227Outbreak of Burkholderia cepacia infection: a systematic study in a hematolo-oncology unit of a tertiary care hospital from Eastern India: 243Outbreak of Burkholderia cepacia infection: a systematic study in a hematolo-oncology unit of a tertiary care hospital from Eastern India: 328 -
CAR-T CELL THERAPY FOR T-CELL MALIGNANCIES CAR-T CELL FOR T-CELL MALIGNANCIES
2500PDF: 2186HTML: 260 -
Pseudo-differentiation syndrome
1575PDF: 743HTML: 10890Figure 1: peripheral blood showing myeloblasts with auer rods: 167Figure 2: CXR upon presentation to the hospital- no infiltrates nor consolidation changes: 147Figure 3: CXR showing pulmonary infiltartes with consolidation: 173Figure 4: CXR after starting steroid therapy- where the infiltrates have melted away: 155Figure 5: barograph showing the rising TLC ad ANC values- associated with worsening symptoms and increasing pulmonary infiltrates in CXR: 150 -
LYON-UNIVERSITY HOSPITAL EXPERIENCE WITH GEMTUZUMAB OZOGAMICIN THERAPY IN ACUTE MYELOID LEUKEMIA: A ‘REAL-LIFE’ STUDY Gemtuzumab ozogamicin in AML
2047PDF: 1265HTML: 354







